These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 807154)

  • 1. R factor-mediated aminoglycoside antibiotic resistance in Pseudomonas aeruginosa: a new aminoglycoside 6'-N-acetyltransferase.
    Kawabe H; Kondo S; Umezawa H; Mitsuhashi S
    Antimicrob Agents Chemother; 1975 May; 7(5):494-9. PubMed ID: 807154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of amikacin, a new semisynthetic antibiotic, by Pseudomonas aeruginosa carrying an R factor.
    Kawabe H; Naito T; Mitsuhashi S
    Antimicrob Agents Chemother; 1975 Jan; 7(1):50-4. PubMed ID: 806257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R factor-mediated resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.
    Sagai H; Krcmery V; Hasuda K; Iyobe S; Knothe H
    Jpn J Microbiol; 1975 Dec; 19(6):427-32. PubMed ID: 820894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic modification of aminoglycoside antibiotics: a new 6'-N-acetylating enzyme from a Pseudomonas aeruginosa isolate.
    Haas M; Biddlecome S; Davies J; Luce CE; Daniels PJ
    Antimicrob Agents Chemother; 1976 Jun; 9(6):945-50. PubMed ID: 820249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentic properties of an R factor carrying resistance to aminolgycoside antibiotics.
    Hasuda K; Krcméry V; Iyobe S; Mitsuhashi S
    J Bacteriol; 1975 Jul; 123(1):329-35. PubMed ID: 1095559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of an R plasmid in Pseudomonas aeruginosa producing amikacin (BB-K8), butirosin, kanamycin, tobramycin, and sisomicin resistance.
    Jacoby GA
    Antimicrob Agents Chemother; 1974 Dec; 6(6):807-10. PubMed ID: 4217586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inactivation of aminoglycoside antibiotics by clinically isolated Pseudomonas aeruginosa].
    Sato K; Kurimoto T; Okachi R
    Jpn J Antibiot; 1983 Jan; 36(1):194-8. PubMed ID: 6405063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on sub-MIC activities of beta-lactam antibiotics and aminoglycoside antibiotics against clinically isolated strain].
    Takahashi M; Ichiman Y; Ohtomo T; Usui Y; Ohshima Y
    Jpn J Antibiot; 1985 Dec; 38(12):3497-504. PubMed ID: 3938820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enhancement of R-plasmid-mediated resistance to aminoglycoside antibiotics by mutations to nitrofurantoin resistance in Escherichia coli.
    Breeze AS; Obaseiki-Ebor EE
    J Antimicrob Chemother; 1984 Nov; 14(5):477-83. PubMed ID: 6392278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance patterns during aminoglycoside restriction.
    Young EJ; Sewell CM; Koza MA; Clarridge JE
    Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin resistance in gram-negative bacilli: occurrence of modifying enzymes and their influence on susceptibility testing.
    Dornbusch K; Hallander HO
    Scand J Infect Dis; 1980; 12(4):295-302. PubMed ID: 6779372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.
    Price KE; Pursiano TA; DeFuria MD
    Antimicrob Agents Chemother; 1974 Feb; 5(2):143-52. PubMed ID: 4209522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of resistance to aminoglycoside antibiotics in nebramycin-producing Streptomyces tenebrarius.
    Yamamoto H; Hotta K; Okami Y; Umezawa H
    J Antibiot (Tokyo); 1982 Aug; 35(8):1020-5. PubMed ID: 7142002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    McNeill WF; John JF; Twitty JA
    Am J Clin Pathol; 1984 Jun; 81(6):742-7. PubMed ID: 6428216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients.
    Shahid M; Malik A
    Indian J Med Res; 2005 Oct; 122(4):324-9. PubMed ID: 16394325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of enzyme-mediated aminoglycoside resistance in gram-negative bacilli isolated in Turkey and the United States.
    Akalin HE; Lolans V
    J Infect Dis; 1983 Dec; 148(6):1128. PubMed ID: 6317771
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of Pseudomonas aeruginosa to gentamicin and related aminoglycoside antibiotics.
    Holmes RK; Minshew BH; Gould IK; Sanford JP
    Antimicrob Agents Chemother; 1974 Sep; 6(3):253-62. PubMed ID: 15830470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.